Aridis Pharmaceuticals Inc (ARDS)
0.0608
0.00 (0.00%)
USD |
OTCM |
May 22, 15:26
Aridis Pharmaceuticals Shareholders Equity (Quarterly): -11.80M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -11.80M |
| June 30, 2023 | -14.91M |
| March 31, 2023 | -27.88M |
| December 31, 2022 | -24.23M |
| September 30, 2022 | -35.82M |
| June 30, 2022 | -27.93M |
| March 31, 2022 | -20.41M |
| December 31, 2021 | -13.11M |
| September 30, 2021 | -4.155M |
| June 30, 2021 | -13.49M |
| March 31, 2021 | -8.555M |
| December 31, 2020 | -8.681M |
| Date | Value |
|---|---|
| September 30, 2020 | -11.30M |
| June 30, 2020 | -6.074M |
| March 31, 2020 | -2.377M |
| December 31, 2019 | 3.636M |
| September 30, 2019 | 8.777M |
| June 30, 2019 | 10.86M |
| March 31, 2019 | 18.71M |
| December 31, 2018 | 26.31M |
| September 30, 2018 | 31.37M |
| June 30, 2018 | 2.182M |
| March 31, 2018 | 3.788M |
| December 31, 2017 | 11.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.82M
Minimum
Sep 2022
10.86M
Maximum
Jun 2019
-11.53M
Average
-11.55M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.534M |
| Total Liabilities (Quarterly) | 18.34M |